Graphic Jump Location
Jonas Salk, MD, in his University of Pittsburgh laboratory, where he and his colleagues created the first workable poliovirus vaccine. Salk originally did polio research as a means of securing funding to establish his laboratory so he could pursue influenza vaccination research.
Salk with Julius Youngner, ScD (right). A key member of Salk[[rsquo]]s core research team, Youngner established techniques for trypsinization and developed a process to inactivate the poliovirus[[rsquo]] ability to infect without destroying its effectiveness as a vaccine.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 2
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.